| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | interleukin-10 receptor activity | 4.60e-05 | 2 | 136 | 2 | GO:0004920 | |
| GeneOntologyBiologicalProcess | microtubule nucleation | 1.94e-06 | 57 | 135 | 6 | GO:0007020 | |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 1.51e-05 | 168 | 135 | 8 | GO:0031109 | |
| GeneOntologyCellularComponent | cis-Golgi network | 2.30e-05 | 85 | 140 | 6 | GO:0005801 | |
| GeneOntologyCellularComponent | Golgi cis cisterna | 6.78e-05 | 33 | 140 | 4 | GO:0000137 | |
| GeneOntologyCellularComponent | Golgi stack | 1.56e-04 | 171 | 140 | 7 | GO:0005795 | |
| GeneOntologyCellularComponent | chromatin | FOXJ2 SP3 CDX2 KAT5 TSHZ2 EBF3 PIAS1 EBF2 SP8 HOXB3 OTP UBA1 HOXC4 ZFHX4 HOXD12 NFATC3 ZFHX2 IRX2 NIPBL ELL NPAS4 FOXF1 | 3.39e-04 | 1480 | 140 | 22 | GO:0000785 |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 4.27e-04 | 94 | 140 | 5 | GO:0032580 | |
| GeneOntologyCellularComponent | spindle pole | 4.71e-04 | 205 | 140 | 7 | GO:0000922 | |
| GeneOntologyCellularComponent | pericentriolar material | 8.52e-04 | 28 | 140 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | microtubule | GOLGA8J MAP1A GOLGA8K SYBU MAP7 NCKAP5L GOLGA8H TUBGCP3 STAU2 TRIM55 PCNT | 9.40e-04 | 533 | 140 | 11 | GO:0005874 |
| MousePheno | abnormal surfactant physiology | 6.01e-06 | 58 | 110 | 6 | MP:0004782 | |
| MousePheno | abnormal body length | TMPRSS15 GOLGA8J ZBTB20 PHRF1 GOLGA8K G2E3 CSMD3 OTP USO1 GOLGA8H STAU2 UNK UNC79 UNC80 PCNT | 2.58e-05 | 550 | 110 | 15 | MP:0001256 |
| Domain | CUB | 1.44e-06 | 49 | 136 | 6 | PF00431 | |
| Domain | CUB | 1.63e-06 | 50 | 136 | 6 | SM00042 | |
| Domain | - | 2.06e-06 | 52 | 136 | 6 | 2.60.120.290 | |
| Domain | CUB | 2.31e-06 | 53 | 136 | 6 | PS01180 | |
| Domain | CUB_dom | 3.57e-06 | 57 | 136 | 6 | IPR000859 | |
| Domain | Homeobox | 5.50e-05 | 234 | 136 | 9 | PF00046 | |
| Domain | HOMEOBOX_1 | 5.87e-05 | 236 | 136 | 9 | PS00027 | |
| Domain | HOX | 6.07e-05 | 237 | 136 | 9 | SM00389 | |
| Domain | HOMEOBOX_2 | 6.47e-05 | 239 | 136 | 9 | PS50071 | |
| Domain | Homeobox_dom | 6.47e-05 | 239 | 136 | 9 | IPR001356 | |
| Domain | Homeobox_CS | 6.62e-05 | 186 | 136 | 8 | IPR017970 | |
| Domain | MAM_1 | 1.97e-04 | 16 | 136 | 3 | PS00740 | |
| Domain | MAM | 2.38e-04 | 17 | 136 | 3 | SM00137 | |
| Domain | MAM | 2.84e-04 | 18 | 136 | 3 | PF00629 | |
| Domain | MAM_dom | 2.84e-04 | 18 | 136 | 3 | IPR000998 | |
| Domain | MAM_2 | 2.84e-04 | 18 | 136 | 3 | PS50060 | |
| Domain | COE | 3.13e-04 | 4 | 136 | 2 | PS01345 | |
| Domain | Transcription_factor_COE | 3.13e-04 | 4 | 136 | 2 | IPR003523 | |
| Domain | COE_HLH | 3.13e-04 | 4 | 136 | 2 | IPR032201 | |
| Domain | COE_DBD | 3.13e-04 | 4 | 136 | 2 | IPR032200 | |
| Domain | Transcription_factor_COE_CS | 3.13e-04 | 4 | 136 | 2 | IPR018350 | |
| Domain | COE1_HLH | 3.13e-04 | 4 | 136 | 2 | PF16423 | |
| Domain | COE1_DBD | 3.13e-04 | 4 | 136 | 2 | PF16422 | |
| Domain | EPHD | 5.26e-04 | 22 | 136 | 3 | PS51805 | |
| Domain | Sushi | 5.55e-04 | 52 | 136 | 4 | PF00084 | |
| Domain | CCP | 6.42e-04 | 54 | 136 | 4 | SM00032 | |
| Domain | ZF_PHD_2 | 6.52e-04 | 95 | 136 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 6.84e-04 | 96 | 136 | 5 | PS01359 | |
| Domain | SUSHI | 7.37e-04 | 56 | 136 | 4 | PS50923 | |
| Domain | Homeodomain-like | 7.38e-04 | 332 | 136 | 9 | IPR009057 | |
| Domain | Sushi_SCR_CCP_dom | 7.88e-04 | 57 | 136 | 4 | IPR000436 | |
| Domain | IPT | 9.72e-04 | 27 | 136 | 3 | SM00429 | |
| Domain | TLV_coat | 1.08e-03 | 7 | 136 | 2 | PF00429 | |
| Domain | - | 1.11e-03 | 283 | 136 | 8 | 1.10.10.60 | |
| Domain | Znf_U1 | 1.20e-03 | 29 | 136 | 3 | IPR003604 | |
| Domain | ZnF_U1 | 1.20e-03 | 29 | 136 | 3 | SM00451 | |
| Domain | TLV/ENV_coat_polyprotein | 1.43e-03 | 8 | 136 | 2 | IPR018154 | |
| Domain | TIG | 1.46e-03 | 31 | 136 | 3 | PF01833 | |
| Domain | IPT | 1.60e-03 | 32 | 136 | 3 | IPR002909 | |
| Domain | HTH_motif | 1.61e-03 | 69 | 136 | 4 | IPR000047 | |
| Domain | Sp1_fam | 2.28e-03 | 10 | 136 | 2 | IPR030450 | |
| Pathway | WP_15Q11Q13_COPY_NUMBER_VARIATION | 3.07e-05 | 59 | 87 | 5 | M48104 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ZSWIM8 GAK RAE1 MAP1A ZNF318 CEP192 ZCCHC2 MAP7 NCKAP5L PIAS1 SETDB1 USO1 NFATC3 UNK DNMBP PCNT HDLBP CDCA4 | 3.95e-11 | 588 | 142 | 18 | 38580884 |
| Pubmed | 6.66e-08 | 3 | 142 | 3 | 12906867 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PABIR1 MYCBP2 FRYL CEP192 PLEKHG2 MAP7 N4BP3 NCKAP5L PRAG1 NHSL1 USO1 NFATC3 CASKIN2 STARD9 PEAK1 DNMBP SRRM2 | 9.44e-08 | 861 | 142 | 17 | 36931259 |
| Pubmed | USP36 ZSWIM8 KAT5 RAE1 MAP1A PHRF1 ZNF318 MAP7 NCKAP5L SIRT5 SETDB1 ZNF469 ZFHX4 TUBGCP3 CSMD1 SRRM2 IRX2 UNC80 RAI1 | 1.57e-07 | 1116 | 142 | 19 | 31753913 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | KAT5 RAE1 SOBP NUP214 BCL9 PIAS1 KMT2C ZFHX4 ASXL2 NIPBL RAI1 | 2.32e-07 | 351 | 142 | 11 | 38297188 |
| Pubmed | 2.58e-07 | 14 | 142 | 4 | 30630895 | ||
| Pubmed | GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules. | 3.51e-07 | 15 | 142 | 4 | 26165940 | |
| Pubmed | Golgi disruption and early embryonic lethality in mice lacking USO1. | 3.51e-07 | 15 | 142 | 4 | 23185636 | |
| Pubmed | 7.80e-07 | 18 | 142 | 4 | 15800058 | ||
| Pubmed | The mammalian SPD-2 ortholog Cep192 regulates centrosome biogenesis. | 1.32e-06 | 6 | 142 | 3 | 18207742 | |
| Pubmed | Mechanism of primitive duct formation in the pancreas and submandibular glands: a role for SDF-1. | 1.51e-06 | 21 | 142 | 4 | 20003423 | |
| Pubmed | 1.51e-06 | 21 | 142 | 4 | 23386608 | ||
| Pubmed | 1.84e-06 | 22 | 142 | 4 | 34897463 | ||
| Pubmed | USP36 ZNF280C PHRF1 G2E3 SYNPO ERI2 KMT2C CASKIN2 MRC2 UNK DNMBP RAI1 | 1.97e-06 | 529 | 142 | 12 | 14621295 | |
| Pubmed | GOLGA8J MYCBP2 EBF3 SYNE1 GOLGA8K SYNPO ZNF318 BCL9 TENM2 UBA1 NFATC3 GOLGA8H UNC79 NIPBL RAI1 PCNT | 2.21e-06 | 963 | 142 | 16 | 28671696 | |
| Pubmed | 2.50e-06 | 209 | 142 | 8 | 36779422 | ||
| Pubmed | Essential role of cyclin-G-associated kinase (Auxilin-2) in developing and mature mice. | 2.66e-06 | 24 | 142 | 4 | 18434600 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZBTB20 MYCBP2 TSHZ2 SOBP ZDHHC14 STAP2 G2E3 SYNPO CPD FRYL CEP192 KLKP1 NEDD1 KMT2C HOXC4 PTPRG ZFHX2 CSMD1 RAI1 PCNT | 2.90e-06 | 1489 | 142 | 20 | 28611215 |
| Pubmed | 3.15e-06 | 25 | 142 | 4 | 29587143 | ||
| Pubmed | CFP1 Regulates Histone H3K4 Trimethylation and Developmental Potential in Mouse Oocytes. | 3.15e-06 | 25 | 142 | 4 | 28768200 | |
| Pubmed | Dual function of Yap in the regulation of lens progenitor cells and cellular polarity. | 3.71e-06 | 26 | 142 | 4 | 24384391 | |
| Pubmed | Mouse oocytes develop in cysts with the help of nurse cells. | 3.71e-06 | 26 | 142 | 4 | 35623357 | |
| Pubmed | Dynein activating adaptor BICD2 controls radial migration of upper-layer cortical neurons in vivo. | 3.71e-06 | 26 | 142 | 4 | 31655624 | |
| Pubmed | PTEN dephosphorylates Abi1 to promote epithelial morphogenesis. | 3.71e-06 | 26 | 142 | 4 | 32673396 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 6.23e-06 | 168 | 142 | 7 | 30631154 | |
| Pubmed | PABIR1 USP36 MYCBP2 ZNF280C GPRIN3 CPD CEP192 NCKAP5L NHSL1 UBA1 PTPRG CASKIN2 PEAK1 SRRM2 PCNT HDLBP | 6.52e-06 | 1049 | 142 | 16 | 27880917 | |
| Pubmed | SYNE1 NUP214 CEP192 CSMD3 TENM2 SETDB1 STARD9 ASXL2 SRRM2 PCNT | 7.27e-06 | 407 | 142 | 10 | 12693553 | |
| Pubmed | Failure of epithelial tube maintenance causes hydrocephalus and renal cysts in Dlg5-/- mice. | 7.69e-06 | 31 | 142 | 4 | 17765678 | |
| Pubmed | The Midbrain Preisthmus: A Poorly Known Effect of the Isthmic Organizer. | 1.45e-05 | 75 | 142 | 5 | 37298722 | |
| Pubmed | Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases. | 1.66e-05 | 2 | 142 | 2 | 27531744 | |
| Pubmed | IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. | 1.66e-05 | 2 | 142 | 2 | 22550014 | |
| Pubmed | A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency. | 1.66e-05 | 2 | 142 | 2 | 24089328 | |
| Pubmed | Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. | 1.66e-05 | 2 | 142 | 2 | 19890111 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 18826608 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 21814839 | ||
| Pubmed | IL-10 receptor expression on lymphocytes and monocytes in children with food allergy. | 1.66e-05 | 2 | 142 | 2 | 33595140 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 24387768 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 22357847 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 28267044 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 24785691 | ||
| Pubmed | A genetic association study of CSMD1 and CSMD2 with cognitive function. | 1.66e-05 | 2 | 142 | 2 | 27890662 | |
| Pubmed | Structure of SgK223 pseudokinase reveals novel mechanisms of homotypic and heterotypic association. | 1.66e-05 | 2 | 142 | 2 | 29079850 | |
| Pubmed | The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | 1.66e-05 | 2 | 142 | 2 | 21439553 | |
| Pubmed | Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | 1.66e-05 | 2 | 142 | 2 | 24408017 | |
| Pubmed | Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis. | 1.66e-05 | 2 | 142 | 2 | 24379584 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 23555306 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 25373860 | ||
| Pubmed | 1.76e-05 | 38 | 142 | 4 | 26595272 | ||
| Pubmed | Globozoospermia and lack of acrosome formation in GM130-deficient mice. | 1.85e-05 | 13 | 142 | 3 | 28055014 | |
| Pubmed | GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells. | 1.85e-05 | 13 | 142 | 3 | 33740186 | |
| Pubmed | Loss of GM130 does not impair oocyte meiosis and embryo development in mice. | 1.85e-05 | 13 | 142 | 3 | 32873390 | |
| Pubmed | 1.85e-05 | 13 | 142 | 3 | 21552007 | ||
| Pubmed | GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver. | 1.85e-05 | 13 | 142 | 3 | 29128360 | |
| Pubmed | Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice. | 1.85e-05 | 13 | 142 | 3 | 28028212 | |
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 1.99e-05 | 80 | 142 | 5 | 19389623 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXJ2 SP3 CDX2 TSHZ2 EBF3 HOXB3 OTP HOXC4 ZFHX4 HOXD12 NFATC3 ZFHX2 IRX2 FOXF1 | 2.26e-05 | 908 | 142 | 14 | 19274049 |
| Pubmed | 2.35e-05 | 14 | 142 | 3 | 37831422 | ||
| Pubmed | Golgb1 regulates protein glycosylation and is crucial for mammalian palate development. | 2.35e-05 | 14 | 142 | 3 | 27226319 | |
| Pubmed | Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice. | 2.35e-05 | 14 | 142 | 3 | 33543287 | |
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 2.67e-05 | 85 | 142 | 5 | 16051665 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | GPC1 ZSWIM8 GPRIN3 NUP214 NEDD1 SCUBE1 TUBGCP3 STAU2 UNK HDLBP | 2.74e-05 | 475 | 142 | 10 | 31040226 |
| Pubmed | Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum. | 2.92e-05 | 15 | 142 | 3 | 17204322 | |
| Pubmed | 2.92e-05 | 15 | 142 | 3 | 16413118 | ||
| Pubmed | The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. | 2.92e-05 | 15 | 142 | 3 | 17046993 | |
| Pubmed | Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body. | 2.92e-05 | 15 | 142 | 3 | 17189423 | |
| Pubmed | 2.92e-05 | 15 | 142 | 3 | 26083584 | ||
| Pubmed | 2.92e-05 | 15 | 142 | 3 | 37635409 | ||
| Pubmed | Golga5 is dispensable for mouse embryonic development and postnatal survival. | 2.92e-05 | 15 | 142 | 3 | 28509431 | |
| Pubmed | 3.52e-05 | 90 | 142 | 5 | 15033168 | ||
| Pubmed | 3.59e-05 | 16 | 142 | 3 | 16399995 | ||
| Pubmed | 3.59e-05 | 16 | 142 | 3 | 11784862 | ||
| Pubmed | p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis. | 3.59e-05 | 16 | 142 | 3 | 21640725 | |
| Pubmed | 3.59e-05 | 16 | 142 | 3 | 16336229 | ||
| Pubmed | 3.59e-05 | 16 | 142 | 3 | 18166528 | ||
| Pubmed | Nipbl and mediator cooperatively regulate gene expression to control limb development. | 3.59e-05 | 16 | 142 | 3 | 25255084 | |
| Pubmed | FOXJ2 SP3 ZBTB20 EBF3 ZNF318 PIAS1 KMT2C OTP HOXD12 ZFHX2 IRX2 NPAS4 | 3.66e-05 | 709 | 142 | 12 | 22988430 | |
| Pubmed | GAK MYCBP2 SYNE1 CPD CEP192 HSPBP1 MAP7 NCKAP5L CASKIN2 TUBGCP3 STAU2 COL14A1 ALAS1 PEAK1 SRRM2 PCNT EPHA7 HDLBP | 3.77e-05 | 1487 | 142 | 18 | 33957083 | |
| Pubmed | Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. | 4.35e-05 | 17 | 142 | 3 | 14718562 | |
| Pubmed | 4.35e-05 | 17 | 142 | 3 | 28717168 | ||
| Pubmed | 4.35e-05 | 17 | 142 | 3 | 27655914 | ||
| Pubmed | 4.35e-05 | 17 | 142 | 3 | 14728599 | ||
| Pubmed | 4.35e-05 | 17 | 142 | 3 | 20004763 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 4.56e-05 | 95 | 142 | 5 | 29643511 | |
| Pubmed | RAE1 MYCBP2 EBF3 ZNF318 BCL9 NEDD1 PIAS1 KMT2C UBA1 TUBGCP3 ASXL2 SRRM2 NIPBL RAI1 HDLBP | 4.82e-05 | 1103 | 142 | 15 | 34189442 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 16982608 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 28982901 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 9312047 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 26708753 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 37511050 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 22549091 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 30167850 | ||
| Pubmed | Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site. | 4.95e-05 | 3 | 142 | 2 | 11485736 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 9151732 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 24581234 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 25733167 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 21532858 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 30998505 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 32016805 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 28678006 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 23096091 | ||
| Cytoband | 15q13.2 | 3.70e-05 | 21 | 142 | 3 | 15q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q13 | 2.73e-04 | 100 | 142 | 4 | chr15q13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 3.93e-05 | 15 | 82 | 3 | 529 | |
| GeneFamily | HOXL subclass homeoboxes | 9.02e-05 | 52 | 82 | 4 | 518 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.29e-04 | 57 | 82 | 4 | 1179 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.73e-04 | 181 | 82 | 6 | 694 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 7.17e-04 | 9 | 82 | 2 | 755 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.35e-03 | 66 | 82 | 3 | 722 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 4.03e-03 | 21 | 82 | 2 | 813 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.16e-03 | 718 | 82 | 9 | 28 | |
| GeneFamily | Fibronectin type III domain containing | 6.05e-03 | 160 | 82 | 4 | 555 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GOLGA8J MYCBP2 TSHZ2 EBF3 SOBP GPRIN3 ZNF318 SYBU CSMD2 CSMD3 TENM2 SLC7A14 EBF2 MMP24 OTP ZFHX4 ZFHX2 CSMD1 IRX2 UNC79 RAI1 | 3.94e-07 | 1106 | 139 | 21 | M39071 |
| Coexpression | MORI_MATURE_B_LYMPHOCYTE_UP | 1.18e-05 | 95 | 139 | 6 | M17083 | |
| Coexpression | MORI_MATURE_B_LYMPHOCYTE_UP | 2.20e-05 | 106 | 139 | 6 | MM595 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | FOXJ2 MYCBP2 EBF3 CPD NUP214 BCL9 TENM2 PRR16 SP8 SETDB1 ZFHX4 PTPRG MRC2 MAMDC2 ASXL2 ASPRV1 IRX2 FOXF1 EPHA7 HDLBP | 3.06e-07 | 806 | 139 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | EBF3 CPD CSMD3 TENM2 SLC7A14 SP8 SETDB1 ZFHX4 MAMDC2 COL14A1 ASXL2 FOXF1 EPHA7 | 4.82e-06 | 427 | 139 | 13 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | SP3 MYCBP2 EBF3 CPD NUP214 TENM2 PRR16 SP8 SETDB1 ZFHX4 PTPRG MAMDC2 ASXL2 ASPRV1 DNMBP IRX2 FOXF1 EPHA7 | 5.52e-06 | 806 | 139 | 18 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.50e-05 | 152 | 139 | 7 | gudmap_developingKidney_e15.5_S-shaped body_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | FOXJ2 ZBTB20 MYCBP2 EBF3 CPD NUP214 MAP7 BCL9 TENM2 NUDT4 COL14A1 ASXL2 DNMBP IRX2 EPHA7 HDLBP | 6.62e-05 | 795 | 139 | 16 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | EBF3 NUP214 BCL9 TENM2 SP8 ZFHX4 MAMDC2 ASXL2 IRX2 FOXF1 EPHA7 | 7.81e-05 | 407 | 139 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | CPD TENM2 PRR16 SP8 SETDB1 ZFHX4 ASXL2 ASPRV1 IRX2 FOXF1 EPHA7 | 7.98e-05 | 408 | 139 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | MYCBP2 EBF3 CPD CSMD3 PIAS1 TENM2 SLC7A14 SP8 SETDB1 ZFHX4 PTPRG MAMDC2 COL14A1 ASXL2 FOXF1 EPHA7 | 9.24e-05 | 818 | 139 | 16 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | TMPRSS15 CDX2 MXRA5 MAP1A TSHZ2 EBF3 EBF2 PRR16 HOXB3 ZNF469 SCUBE1 HOXC4 ZFHX4 MRC2 MAMDC2 HPX NPAS4 FOXF1 EPHA7 | 9.58e-05 | 1094 | 139 | 19 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_200 | 1.09e-04 | 165 | 139 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.20e-04 | 312 | 139 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | NK cells, NK.49CI+.Sp, NK1.1+ CD3- Ly49C/I+, Spleen, avg-3 | GPC1 IL10RA ZBTB20 LAT2 GPRIN3 FRYL PRAG1 NFATC3 CRYBG1 PEAK1 | 2.29e-04 | 385 | 139 | 10 | GSM538285_500 |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#3_top-relative-expression-ranked_200 | 2.88e-04 | 20 | 139 | 3 | gudmap_developingKidney_e11.5_metaneph mesench_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 2.99e-04 | 89 | 139 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | MYCBP2 CPD NUP214 BCL9 TENM2 SLC7A14 SP8 ZFHX4 PTPRG COL14A1 ASXL2 DNMBP FOXF1 EPHA7 HDLBP | 3.10e-04 | 818 | 139 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | FOXJ2 TSHZ2 SYNE1 SYNPO BCL9 PRR16 NUDT4 ZFHX4 STARD9 STAU2 ALAS1 PEAK1 EPHA7 | 3.12e-04 | 642 | 139 | 13 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | TSHZ2 SYNE1 TICAM1 SYNPO BCL9 SLC7A14 PRR16 ZFHX4 STARD9 STAU2 ALAS1 PEAK1 FOXF1 EPHA7 | 3.21e-04 | 731 | 139 | 14 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-09 | 184 | 142 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-09 | 184 | 142 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-09 | 184 | 142 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.41e-07 | 184 | 142 | 8 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 2.04e-07 | 193 | 142 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.12e-07 | 194 | 142 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.57e-07 | 199 | 142 | 8 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.67e-07 | 200 | 142 | 8 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.67e-07 | 200 | 142 | 8 | 64d2941689d7ca8af54f9ba21c5aeabf719084ef | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.67e-07 | 200 | 142 | 8 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.67e-07 | 200 | 142 | 8 | 76f3043cb88071256ff661885fe5a82a54f5b733 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.77e-06 | 179 | 142 | 7 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | Substantia_nigra|World / BrainAtlas - Mouse McCarroll V32 | 1.89e-06 | 115 | 142 | 6 | 18174b8d57d444fab1e9d2b13d22939c83c958e0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-06 | 182 | 142 | 7 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.37e-06 | 187 | 142 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.46e-06 | 188 | 142 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.55e-06 | 189 | 142 | 7 | 473b01c9162b12b90a617c600238436177a0d18d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.64e-06 | 190 | 142 | 7 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.64e-06 | 190 | 142 | 7 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | COVID-19-Heart-Mito_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.64e-06 | 190 | 142 | 7 | ea74e0e38bcaba125b48c88331e9ba09228d3178 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.73e-06 | 191 | 142 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.82e-06 | 192 | 142 | 7 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.82e-06 | 192 | 142 | 7 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 193 | 142 | 7 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.92e-06 | 193 | 142 | 7 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-06 | 193 | 142 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-06 | 194 | 142 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-06 | 125 | 142 | 6 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.13e-06 | 195 | 142 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.24e-06 | 196 | 142 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 3.35e-06 | 197 | 142 | 7 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.35e-06 | 197 | 142 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.35e-06 | 197 | 142 | 7 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.46e-06 | 198 | 142 | 7 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.46e-06 | 198 | 142 | 7 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.46e-06 | 198 | 142 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.46e-06 | 198 | 142 | 7 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.46e-06 | 198 | 142 | 7 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.46e-06 | 198 | 142 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.58e-06 | 199 | 142 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.58e-06 | 199 | 142 | 7 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.58e-06 | 199 | 142 | 7 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.70e-06 | 200 | 142 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 200 | 142 | 7 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 200 | 142 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.42e-06 | 149 | 142 | 6 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-06 | 151 | 142 | 6 | 10da94037225a71844281ddcb395072250a78094 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-05 | 170 | 142 | 6 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-05 | 177 | 142 | 6 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-05 | 177 | 142 | 6 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.24e-05 | 177 | 142 | 6 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.46e-05 | 180 | 142 | 6 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.62e-05 | 182 | 142 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-05 | 186 | 142 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 187 | 142 | 6 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 187 | 142 | 6 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 187 | 142 | 6 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 187 | 142 | 6 | 9225caf66e06ebe57e90d677122acb6498607f36 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.14e-05 | 188 | 142 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 189 | 142 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.23e-05 | 189 | 142 | 6 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-05 | 190 | 142 | 6 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-05 | 190 | 142 | 6 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-05 | 190 | 142 | 6 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.43e-05 | 191 | 142 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.43e-05 | 191 | 142 | 6 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.43e-05 | 191 | 142 | 6 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-05 | 191 | 142 | 6 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.43e-05 | 191 | 142 | 6 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.43e-05 | 191 | 142 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-05 | 192 | 142 | 6 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.53e-05 | 192 | 142 | 6 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.53e-05 | 192 | 142 | 6 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-05 | 192 | 142 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-05 | 192 | 142 | 6 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-05 | 192 | 142 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.64e-05 | 193 | 142 | 6 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-05 | 193 | 142 | 6 | 68089ba4123e2f9bea9aae0023a844b5a57bfc0e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.74e-05 | 194 | 142 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-05 | 194 | 142 | 6 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-05 | 194 | 142 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.85e-05 | 195 | 142 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.85e-05 | 195 | 142 | 6 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-05 | 195 | 142 | 6 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.85e-05 | 195 | 142 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 3.85e-05 | 195 | 142 | 6 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 195 | 142 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 195 | 142 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.96e-05 | 196 | 142 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.96e-05 | 196 | 142 | 6 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.96e-05 | 196 | 142 | 6 | 57df2a57b35be9851ac0b1e5731baa53052511f0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.96e-05 | 196 | 142 | 6 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.08e-05 | 197 | 142 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 197 | 142 | 6 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.08e-05 | 197 | 142 | 6 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.08e-05 | 197 | 142 | 6 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.08e-05 | 197 | 142 | 6 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.08e-05 | 197 | 142 | 6 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 4.08e-05 | 197 | 142 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 197 | 142 | 6 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 3.07e-06 | 198 | 136 | 9 | 4370_DN | |
| Disease | cortical thickness | ZNF438 B4GALNT1 MYCBP2 ZNF318 SYBU TENM2 NHSL1 SP8 ZNF469 SCUBE1 COL21A1 STAU2 SHARPIN MYO16 ELL EPHA7 | 4.31e-05 | 1113 | 133 | 16 | EFO_0004840 |
| Disease | lung cancer | 1.12e-04 | 21 | 133 | 3 | MONDO_0008903 | |
| Disease | melanoma | 1.38e-04 | 248 | 133 | 7 | C0025202 | |
| Disease | bipolar I disorder | 4.57e-04 | 141 | 133 | 5 | EFO_0009963 | |
| Disease | coronary aneurysm | 5.27e-04 | 35 | 133 | 3 | EFO_1000881 | |
| Disease | anemia (phenotype), response to ribavirin | 7.11e-04 | 9 | 133 | 2 | EFO_0004272, GO_1901559 | |
| Disease | response to anticoagulant | 8.42e-04 | 41 | 133 | 3 | GO_0061476 | |
| Disease | Psychotic Disorders | 1.15e-03 | 101 | 133 | 4 | C0033975 | |
| Disease | dimethylglycine measurement | 1.18e-03 | 46 | 133 | 3 | EFO_0010476 | |
| Disease | brain disease (is_implicated_in) | 1.29e-03 | 12 | 133 | 2 | DOID:936 (is_implicated_in) | |
| Disease | S-7-hydroxywarfarin measurement | 1.57e-03 | 110 | 133 | 4 | EFO_0803329 | |
| Disease | response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin | 1.77e-03 | 14 | 133 | 2 | EFO_0005400, GO_0036275, GO_1902518, GO_1902520 | |
| Disease | Drug habituation | 1.85e-03 | 115 | 133 | 4 | C0013170 | |
| Disease | Substance-Related Disorders | 1.85e-03 | 115 | 133 | 4 | C0236969 | |
| Disease | Drug abuse | 1.85e-03 | 115 | 133 | 4 | C0013146 | |
| Disease | Drug Use Disorders | 1.85e-03 | 115 | 133 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.85e-03 | 115 | 133 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.85e-03 | 115 | 133 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.85e-03 | 115 | 133 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.85e-03 | 115 | 133 | 4 | C0029231 | |
| Disease | Prescription Drug Abuse | 1.85e-03 | 115 | 133 | 4 | C4316881 | |
| Disease | cleft lip | 1.86e-03 | 284 | 133 | 6 | EFO_0003959 | |
| Disease | Metastatic melanoma | 1.88e-03 | 54 | 133 | 3 | C0278883 | |
| Disease | Substance abuse problem | 1.91e-03 | 116 | 133 | 4 | C0740858 | |
| Disease | urate measurement, bone density | 2.02e-03 | 619 | 133 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | smoking status measurement | ZNF438 ZBTB20 TSHZ2 ZDHHC14 TENM2 EBF2 SP8 HOXB3 PTPRG ZNF804B UNC79 ELL EPHA7 | 2.29e-03 | 1160 | 133 | 13 | EFO_0006527 |
| Disease | amygdala volume change measurement | 2.32e-03 | 16 | 133 | 2 | EFO_0021490 | |
| Disease | hippocampal volume | 2.33e-03 | 297 | 133 | 6 | EFO_0005035 | |
| Disease | RS-warfarin measurement | 2.73e-03 | 128 | 133 | 4 | EFO_0803325 | |
| Disease | cortical thickness change measurement | 2.94e-03 | 18 | 133 | 2 | EFO_0021501 | |
| Disease | Chronic myeloproliferative disorder | 3.28e-03 | 19 | 133 | 2 | C1292778 | |
| Disease | Nonorganic psychosis | 3.78e-03 | 69 | 133 | 3 | C0349204 | |
| Disease | sex interaction measurement, COVID-19 | 4.00e-03 | 21 | 133 | 2 | EFO_0008343, MONDO_0100096 | |
| Disease | pulse pressure measurement | ZNF438 USP36 MXRA5 FRYL ZNF318 ZCCHC2 EBF2 PRR16 HOXB3 HOXC4 ZFHX4 COL21A1 MRC2 ELL | 4.14e-03 | 1392 | 133 | 14 | EFO_0005763 |
| Disease | Seckel syndrome | 4.39e-03 | 22 | 133 | 2 | C0265202 | |
| Disease | blood pressure | 4.39e-03 | 22 | 133 | 2 | EFO_0004325 | |
| Disease | triacylglycerol 48:3 measurement | 4.39e-03 | 22 | 133 | 2 | EFO_0010406 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NPLGTEASKVCSSPP | 336 | P23470 | |
| PLPPSSRLQDSCKQG | 446 | Q6UXC1 | |
| PLLSGGTKRNPCSPQ | 526 | A8K979 | |
| SCASGLLQTLNPGPP | 131 | Q99626 | |
| KLCQPQSTGSLLGDP | 291 | P55199 | |
| GSVGSPDQLPLACSP | 186 | Q15834 | |
| SCGSLSFPPNGNKIG | 2621 | Q96PZ7 | |
| LSSCPEPAVPSNGVK | 1906 | Q7Z408 | |
| SCPEPQTPSSGIKIG | 2051 | Q7Z407 | |
| SCESSGGGLPLPFQK | 81 | Q00973 | |
| GLTASPKAGPCSTPT | 1076 | Q96L96 | |
| IRPQGSPSPACSSGN | 546 | Q9HAK2 | |
| SGSCQKQPQDASPPP | 1396 | Q6XZF7 | |
| KSTVPLGGPLSPACN | 211 | B6SEH9 | |
| QSGCPSPTIPAGKVI | 141 | Q76L83 | |
| SIGCLSFSPPTLPGN | 41 | P78406 | |
| CKAPGASPGNPLSPS | 1346 | Q7Z5J4 | |
| IQLGSCSSSEKLPPP | 491 | Q7Z304 | |
| LGDRPSTPGTKPNIC | 366 | Q9Y5R2 | |
| FPLKTGTRQGCPLSP | 651 | O00370 | |
| KTCTPAPGTVSNANP | 3361 | Q8NEZ4 | |
| KGPSPPLNGNILSCS | 2071 | P78559 | |
| ALPCTTNAPGNGKPV | 641 | Q14244 | |
| SIPEKATSGGCQPPR | 41 | H3BQL2 | |
| CEPPINGSSTPNPKI | 541 | Q8NHV4 | |
| IPCRNSGSDGSPSPL | 486 | Q9HCH0 | |
| PLPATSQGTASKCPF | 96 | P13196 | |
| NSAPVAGPCSSFPKI | 1621 | Q9Y6X6 | |
| GQKTSAASCPQPPTF | 526 | P35052 | |
| AAGPSSGSCPPTKFQ | 46 | Q9NPF0 | |
| TPGNVSIECLPGSSP | 176 | P98073 | |
| PGGEPDQPLSSSSCL | 126 | Q92993 | |
| KSTVPLGGPLSPACN | 211 | B6SEH8 | |
| LPGKSGSSPSQSPCS | 716 | Q5SYE7 | |
| GCSPANGNSTVPSLP | 146 | Q9NZJ9 | |
| CFQPGLSSKPGPGVL | 726 | Q9Y5G2 | |
| ITSGTGPNVPPRKNC | 551 | Q9H792 | |
| LSLCGPESGLPKNPS | 2366 | O94915 | |
| QPVCSPAGSEGTPKG | 276 | Q6KC79 | |
| KGCLQPRALPSGSPA | 556 | Q9P1Y6 | |
| SLKPSGPTPASGQLS | 1171 | P35658 | |
| ICQKGTDPSLSPSPA | 1106 | Q9UBG0 | |
| GLPCSQSKVSPPGTA | 61 | Q107X0 | |
| GLCALSGPAPAPQSL | 166 | Q96CW5 | |
| GICLQEPSLSPSTGP | 371 | Q13651 | |
| ASGTKDACPEPQGPS | 56 | Q8WV35 | |
| SQAGPPGSSRKCSPG | 31 | Q9P0K8 | |
| KCSPGSPTDPNATLS | 41 | Q9P0K8 | |
| PSPTRGIGKQCFSPS | 146 | Q96E09 | |
| NPNSLKTPLGTCSRP | 896 | Q15375 | |
| TSLPQTQGPGLLCSP | 2266 | O95613 | |
| TERPPKLCSSLPGQG | 736 | Q8WXE0 | |
| ATSDLKQPSLGPGCG | 336 | Q9BZI1 | |
| TNEGFPNPPCTEGKT | 1861 | Q9UMZ3 | |
| PNPPCTEGKTKFSGN | 1866 | Q9UMZ3 | |
| SNLCPPELAKASGSP | 826 | Q5K4E3 | |
| PSAGVPCANSPLGSN | 336 | O15488 | |
| PSPSSPGNGDCTLLA | 576 | Q8IUM7 | |
| GPCGSLKAPSPRSSA | 381 | O43613 | |
| CGVDLPPPGSTTSSK | 1351 | O60494 | |
| LSCLLGPPEAASQGP | 911 | O14976 | |
| ATGCSSIPPAGFKPT | 636 | Q7L622 | |
| LTCLSLPGSPGKTAP | 26 | Q6PRD7 | |
| SIPEKATSGGCQPPR | 41 | D6RF30 | |
| SAPGKTLPSSGPQNL | 821 | Q05707 | |
| LGSPSGNLKSPQTPS | 876 | O00512 | |
| KSGPPKCGPGTNSTL | 111 | P14651 | |
| PEKSQSLCEPAPLSG | 91 | P09017 | |
| TPGSTTLLQGAPCAP | 146 | P35452 | |
| GQPSCPNKSDENIPG | 1136 | O75976 | |
| LNGPSDVGSTPAPCI | 431 | Q96P44 | |
| SIPEKATSGGCQPPR | 41 | A6NMD2 | |
| RSCGPPPQLSNGEVK | 206 | Q9BXR6 | |
| KQNPGDSCSLGTPPG | 306 | Q08334 | |
| SVPEKATSGGCQPPG | 41 | P0CJ92 | |
| VISSGSKPLSPGPCL | 1746 | Q8TEP8 | |
| PACKTPGKPAGQQSD | 1556 | Q9ULL0 | |
| CQPASLKGNSCPPKT | 131 | Q3LI81 | |
| LGVQSPLPPVTGSNC | 666 | Q8WXE1 | |
| SQPTTEGAPPCGLNK | 876 | Q9Y4K1 | |
| ASPPPSCTSANGNGL | 571 | Q9H4W6 | |
| QPEKPSCPVGGVLSS | 166 | Q6ZVF9 | |
| GLGPSCSDAPTTPIK | 471 | Q8IWY4 | |
| LPGPSNVSGSPQLCS | 281 | Q5XKR4 | |
| KTGPTSGLCPSASPE | 171 | Q9GZY6 | |
| SPCNPAANPLSGSLS | 291 | Q12946 | |
| KSLGPNSCSANGPGL | 411 | P02790 | |
| LPLALPPASQGCSSG | 11 | Q9NZL4 | |
| VSPTNPPGATSSCQK | 291 | O60763 | |
| CTGGPKPLSPASSQD | 281 | Q9UGK3 | |
| GPSLSGSKSPCPQEK | 1006 | Q9UQ35 | |
| GKCSLSQPGPSVSSP | 8701 | Q8NF91 | |
| ENSSAGLDIPGPPCT | 256 | Q8N967 | |
| AAPSGSGLPKPADCL | 166 | Q58EX7 | |
| SKPSTLCADGQPQAP | 376 | Q8N3V7 | |
| EIPKCSNSPGPLGKS | 86 | Q5VWT5 | |
| KGNPSSSCPAEGPPA | 6 | Q569H4 | |
| GLTLCPSQPSNPGVL | 291 | Q9Y336 | |
| ATALPTGTSKCPPSQ | 6 | Q8IUQ4 | |
| GSKSNSPPALGPEAC | 126 | Q9H0F6 | |
| RACSGPQQASSSGPP | 226 | Q9NT68 | |
| LKSFGPPVSCSPLGQ | 96 | Q6ZUB0 | |
| GCPTLVQALPGPSTQ | 981 | O75592 | |
| CDSKINPSSPPGIVG | 1341 | Q9P2P6 | |
| CPSLSPTSPLNNKGI | 481 | O75925 | |
| APDGQPQKASLPSAC | 651 | Q9NZP6 | |
| CNKIGSPSPSPSSLS | 6 | Q8IXZ3 | |
| GGCNPPSSEETPKNK | 966 | Q15047 | |
| CAPPTGFNKPTSNDT | 151 | Q53R12 | |
| CVGLGNSKTPPPGQA | 461 | Q9H6R3 | |
| QPTAPAPSCLPKAGQ | 31 | Q53RT3 | |
| EGLAPATPGPSSSCK | 211 | Q9BXL8 | |
| KLPPPQGSSESCTVN | 816 | Q9C0B9 | |
| PATNTCGAKNLPSLG | 476 | Q8TBB6 | |
| LKSFGPPVSCSPLGQ | 96 | P0C874 | |
| PNTSLSGCGTPSPSK | 746 | Q86UP3 | |
| RKATTNPPCTPGSEG | 451 | Q9BYV6 | |
| GPLCKNGSPSPDFAE | 26 | A4D1E1 | |
| GQLQGCSPAPSRKPE | 3131 | Q8N2C7 | |
| EDGGLCPPLNQSSPT | 381 | Q9C0A1 | |
| CPPLNQSSPTSKEGG | 386 | Q9C0A1 | |
| GLKGSSPTPPCSPVQ | 481 | Q9NUL3 | |
| NSPAKTLPGACGSPQ | 1096 | Q9UBZ9 | |
| KTPSDAGNSPIGFCP | 91 | Q9NX95 | |
| DSPPGCSGQALSLAP | 596 | A7XYQ1 | |
| LLAATCSKIGPPSPG | 61 | Q02447 | |
| NLGCLPPSSALPSGT | 161 | Q8IUC6 | |
| GGPKPFECPSIQITS | 101 | Q12968 | |
| KPAGPSTSPDGNSRC | 141 | Q86YV5 | |
| DPKPGSNCSPAQSVL | 16 | P22314 | |
| KPQPLEPTSALSNGC | 666 | Q9NRE2 | |
| LPGKPGLGTPCASLT | 391 | Q8IZN3 | |
| ITQPGGSSAKPGLPC | 21 | Q9HC78 | |
| PGPQLDAGSLAKCSP | 1701 | Q96JG9 | |
| INTVCGAPDPTAGPS | 266 | A7E2V4 | |
| KQPQFPPSCVKGSGL | 6 | Q5T750 | |
| QGLSLSKPSPSLGCG | 6 | Q9H7P9 | |
| LGPLQSKLPTAPFGC | 516 | Q8ND82 | |
| SKLPTAPFGCAPGTS | 521 | Q8ND82 | |
| SGAPDPNCVTVTGLP | 1166 | Q00341 | |
| CPALSGKGAPEPGTQ | 181 | Q9NXA8 | |
| LGSPSNLCGSPPGSI | 376 | Q9C0B0 | |
| PQSGTNKPRETCQGP | 746 | Q7Z4V0 | |
| KTINSAGLGPSPCLP | 2156 | Q5VUA4 | |
| QNGCIPPKLPSGSPS | 501 | Q9P275 | |
| NASSPCLPIPLDAGS | 2431 | Q9P2D8 | |
| EKTNAAAPDCTPGPG | 506 | Q6AW86 | |
| NGETLKLPCTPPGAG | 2651 | Q9NR99 | |
| SQGPKEAGPPAVLSC | 226 | O15049 |